Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 350

1.

Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases.

Vijayan D, Barkauskas DS, Stannard K, Sult E, Buonpane R, Takeda K, Teng MWL, Sachsenmeier K, Hay C, Smyth MJ.

Oncoimmunology. 2017 Apr 5;6(5):e1312044. doi: 10.1080/2162402X.2017.1312044. eCollection 2017.

PMID:
28638737
2.

Ecto-5'-nucleotidase (CD73) regulates peripheral chemoreceptor activity and cardiorespiratory responses to hypoxia.

Holmes AP, Ray CJ, Pearson SA, Coney AM, Kumar P.

J Physiol. 2017 May 31. doi: 10.1113/JP274498. [Epub ahead of print]

PMID:
28560821
3.

CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves.

Liu X, Ma L, Zhang S, Ren Y, Dirksen RT.

J Dent Res. 2017 Jun;96(6):671-677. doi: 10.1177/0022034517692953. Epub 2017 Feb 16.

PMID:
28530470
4.

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians.

Crooke A, Martínez-Henández J, Martínez-López J, Cruz-Jentoft A, Huete-Toral F, Pintor J.

Immun Ageing. 2017 May 19;14:11. doi: 10.1186/s12979-017-0094-3. eCollection 2017.

5.

MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.

Xie M, Qin H, Luo Q, Huang Q, He X, Yang Z, Lan P, Lian L.

BMC Cancer. 2017 May 2;17(1):305. doi: 10.1186/s12885-017-3291-8.

6.

CD73 on T-Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.

Borg N, Alter C, Görldt N, Jacoby C, Ding Z, Steckel B, Quast C, Bönner F, Friebe D, Temme S, Flögel U, Schrader J.

Circulation. 2017 Apr 21. pii: CIRCULATIONAHA.116.023365. doi: 10.1161/CIRCULATIONAHA.116.023365. [Epub ahead of print]

PMID:
28432149
7.

Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review.

Wang R, Zhang Y, Lin X, Gao Y, Zhu Y.

Oncotarget. 2017 Apr 6. doi: 10.18632/oncotarget.16905. [Epub ahead of print]

8.

Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.

Song L, Ye W, Cui Y, Lu J, Zhang Y, Ding N, Hu W, Pei H, Yue Z, Zhou G.

Oncotarget. 2017 May 9;8(19):31977-31992. doi: 10.18632/oncotarget.16667.

9.

Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.

Quast C, Alter C, Ding Z, Borg N, Schrader J.

Circ Heart Fail. 2017 Apr;10(4). pii: e003346. doi: 10.1161/CIRCHEARTFAILURE.116.003346.

PMID:
28404626
10.

Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.

Yang X, Pei S, Wang H, Jin Y, Yu F, Zhou B, Zhang H, Zhang D, Lin D.

BMC Cancer. 2017 Apr 11;17(1):255. doi: 10.1186/s12885-017-3250-4.

11.

The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.

Matyash M, Zabiegalov O, Wendt S, Matyash V, Kettenmann H.

PLoS One. 2017 Apr 4;12(4):e0175012. doi: 10.1371/journal.pone.0175012. eCollection 2017.

12.

CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction.

Hesse J, Leberling S, Boden E, Friebe D, Schmidt T, Ding Z, Dieterich P, Deussen A, Roderigo C, Rose CR, Floss DM, Scheller J, Schrader J.

FASEB J. 2017 Mar 31. pii: fj.201601307R. doi: 10.1096/fj.201601307R. [Epub ahead of print]

PMID:
28363952
13.

Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor.

Arab S, Kheshtchin N, Ajami M, Ashurpoor M, Safvati A, Namdar A, Mirzaei R, Mousavi Niri N, Jadidi-Niaragh F, Ghahremani MH, Hadjati J.

Tumour Biol. 2017 Mar;39(3):1010428317695021. doi: 10.1177/1010428317695021.

PMID:
28349824
14.

Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs.

de Leve S, Wirsdörfer F, Cappuccini F, Schütze A, Meyer AV, Röck K, Thompson LF, Fischer JW, Stuschke M, Jendrossek V.

FASEB J. 2017 Mar 21. pii: fj.201601228R. doi: 10.1096/fj.201601228R. [Epub ahead of print]

PMID:
28325757
15.

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4<sup>+</sup> CD25<sup>high</sup> Foxp3<sup>+</sup> regulatory T-cells in psoriasis.

Han L, Sugiyama H, Zhang Q, Yan K, Fang X, McCormick TS, Cooper KD, Huang Q.

Australas J Dermatol. 2017 Mar 15. doi: 10.1111/ajd.12561. [Epub ahead of print]

PMID:
28295154
16.

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.

Hernandez-Mir G, McGeachy MJ.

PLoS One. 2017 Mar 13;12(3):e0173655. doi: 10.1371/journal.pone.0173655. eCollection 2017.

17.

The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Allard B, Longhi MS, Robson SC, Stagg J.

Immunol Rev. 2017 Mar;276(1):121-144. doi: 10.1111/imr.12528. Review.

PMID:
28258700
18.

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.

Rothe H, Brandenburg V, Haun M, Kollerits B, Kronenberg F, Ketteler M, Wanner C.

PLoS One. 2017 Feb 17;12(2):e0172407. doi: 10.1371/journal.pone.0172407. eCollection 2017.

19.

Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease <i>via</i> CD39-CD73-Adenosine and IDO Signals.

Huang F, Chen M, Chen W, Gu J, Yuan J, Xue Y, Dang J, Su W, Wang J, Zadeh HH, He X, Rong L, Olsen N, Zheng SG.

Front Immunol. 2017 Feb 2;8:68. doi: 10.3389/fimmu.2017.00068. eCollection 2017.

20.

CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.

Gao ZW, Wang HP, Lin F, Wang X, Long M, Zhang HZ, Dong K.

BMC Cancer. 2017 Feb 15;17(1):135. doi: 10.1186/s12885-017-3128-5.

Supplemental Content

Support Center